Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
CSPC Pharmaceutical Group has an analyst consensus of Moderate Buy, with a price target consensus of HK$10.82, a 44.20% upside from current levels. In a report released on May 28, CMB International Securities also maintained a Buy rating on the stock with a HK$13.05 price target.
CHJTF market cap is currently HK$80.98B and has a P/E ratio of 17.13.






